主动脉支架移植物感染管理的最新证据:系统综述与荟萃分析
该系统综述与荟萃分析检索1991年1月至2016年9月文献,纳入11项研究共402例主动脉支架移植物感染患者。手术组生存率高于保守治疗组(58% vs 33%,P=0.002),感染性EVAR生存率高于TEVAR(58% vs 27%,P=0.000),合并主动脉肠瘘者预后更差(生存率72% vs 33%,P=0.002)。
要点
- 手术组生存率58% vs 保守组33%,P=0.002
- 感染性EVAR生存率58% vs TEVAR 27%,P=0.000
- 合并主动脉肠瘘者生存率72% vs 33%,P=0.002
核心结论
- 当前证据提示,在选择的主动脉内移植物感染患者中,手术治疗相较保守管理是更好的选择。
- 感染性TEVAR和合并主动脉肠瘘的患者结局更差。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed和MEDLINE数据库1991年1月至2016年9月全部已发表文献,遵循PRISMA声明。
- 共识别185篇潜在相关文献,最终纳入11项研究、402例患者。
- 数据分析使用SPSS V 22.0。
主要发现
- 402例患者中男性308例(77%),平均年龄范围65至73岁。
- 351例(87%)内移植物为EVAR后植入,51例(13%)为TEVAR后感染。
- 39例(9.7%)患者表现为主动脉破裂;380例有资料患者中92例(24.2%)合并主动脉肠瘘。
- 69例(17%)在医院内或术后30天内死亡,114例(28%)在随访期间死亡。
- 手术组生存率58% vs 保守组33%,P=0.002;感染性EVAR生存率58% vs TEVAR 27%,P=0.000;合并主动脉肠瘘者生存率72% vs 33%,P=0.002。
关键数值与推荐
- 最常用支架移植物为Zenith(Cook Inc, Bloomington, IN)(22%)和Excluder(W.L. Gore, Flagstaff, AZ)(20%)。
- 108例(27%)培养阴性,103例(26%)鉴定出多种微生物。
- 最常分离的微生物为葡萄球菌属(30.1%)、链球菌(14.8%)和真菌(9.2%)。
- 42例(42/401,10%)接受保守治疗,359例(90%)接受手术治疗,包括支架移植物移除加原位重建或解剖外旁路,以及二次腔内手术。
临床怎么用
- 原文结论提示,在选择的主动脉内移植物感染患者中,手术治疗相较保守管理是更好的选择。
- 原文未据此给出其他具体推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aortic stent-graft infection (SGI) is rare but remains one of the most challenging and threatening complications. This systematic review aimed to identify the clinical features, treatment, and outcomes of endograft infection after abdominal endovascular aortic repair (EVAR) and thoracic endovascular aortic repair (TEVAR). METHODS: A systematic literature review of all published literature from January 1991 to September 2016 on SGI was performed under the instruction of Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Aorta, aneurysm, endovascular, stent-graft, endograft and infection were the keywords used in our comprehensive search in PubMed and MEDLINE databases. Data analysis was performed using SPSS, V 22.0. RESULTS: A total of 185 potential relevant articles were identified, but only 11 studies with 402 patients met the inclusion criteria. Majority of the patients were male (308/402, 77%), with a mean age ranging from 65 to 73 years. Most of the endografts were implanted for EVAR (351/402, 87%), while the other 51 (13%) endografts were infected following TEVAR. Among the 402 patients, 39 (9.7%) patients presented with aortic rupture. Ninety-two of 380 (24.2%) patients with available data had aortoenteric fistula (AEF). Sixty-nine patients (17%) died in hospital or within 30 days after operation. One hundred fourteen patients (28%) died during follow-up. The most commonly used stent grafts were Zenith (Cook Inc, Bloomington, IN) (22%) and Excluder (W.L. Gore, Flagstaff, AZ) (20%). Of the 402 patients in this series, 108 patients (27%) had negative culture, and multiple microorganisms were identified in 103 patients (26%). The most frequently isolated microorganisms were Staphylcoccus species (30.1%), Streptococcus (14.8%), and fungus (9.2%). Forty-two patients (42/401, 10%) received conservative treatment, whereas 359 (90%) patients underwent surgical treatment, including stent graft removal with in situ reconstruction or extra-anatomical bypass, and secondary endovascular procedure. Patients in the surgical group had a higher survival rate compared with conservative group (58% vs. 33%, P = 0.002). The survival rate was higher in the patients with infected EVAR than TEVAR (58% vs. 27%, P = 0.000). Patient with AEF had a worse prognosis (survival rate 72% vs. 33%, P = 0.002). CONCLUSIONS: Current evidence suggests that surgical treatment is a better option compared with conservative management in selected patients with aortic endograft infection. The outcome was worse in patients with infected TEVAR and AEF.
引用
- Li HL, Chan YC, Cheng SW, et al. Current Evidence on Management of Aortic Stent-graft Infection: A Systematic Review and Meta-Analysis. Ann Vasc Surg. 2018. PMID: 29772328. doi:10.1016/j.avsg.2018.02.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。